Know Labs, Inc. (KNW)
NYSEAMERICAN: KNW · IEX Real-Time Price · USD
0.560
-0.066 (-10.52%)
Apr 17, 2024, 3:31 PM EDT - Market open
Company Description
Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States.
The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.
The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018.
Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.
Know Labs, Inc.
Country | United States |
Founded | 1998 |
Industry | Scientific & Technical Instruments |
Sector | Technology |
Employees | 12 |
CEO | Ronald P. Erickson J.D. |
Contact Details
Address: 500 Union Street, Suite 810 Seattle, Washington 98101 United States | |
Phone | 206-903-1351 |
Website | knowlabs.co |
Stock Details
Ticker Symbol | KNW |
Exchange | NYSEAMERICAN |
Fiscal Year | October - September |
Reporting Currency | USD |
CIK Code | 0001074828 |
ISIN Number | US4992381032 |
Employer ID | 90-0273142 |
SIC Code | 3829 |
Key Executives
Name | Position |
---|---|
Ronald P. Erickson J.D. | Founder, Chief Executive Officer, Treasurer and Chairman |
Peter Joseph Conley | Chief Financial Officer and Senior Vice President of Intellectual Property |
Jessica English | Chief Marketing Officer |
Dr. James H. Anderson Jr., M.D. | Chief Medical Officer and Chairman of Medical, Scientific and Regulatory Advisory Board |
Steven T. Kent | Chief Product Officer |
Leonardo Trautwein | Chief Commercial Officer |
Jordyn Hujar | Chief of Staff |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 16, 2024 | EFFECT | Notice of Effectiveness |
Apr 12, 2024 | 424B3 | Prospectus |
Apr 9, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Mar 28, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Mar 20, 2024 | 424B5 | Filing |
Mar 20, 2024 | 8-K | Current Report |
Mar 6, 2024 | 8-K/A | [Amend] Current report |
Mar 6, 2024 | 8-K | Current Report |
Feb 29, 2024 | 8-K | Current Report |
Feb 27, 2024 | 8-K | Current Report |